Amendment: SEC Form F-1/A filed by NewGenIvf Group Limited
$NIVF
Misc Health and Biotechnology Services
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
BANGKOK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), today announced that it has entered into a binding term sheet (the "Term Sheet") with White Lion Capital, LLC, ("White Lion") a California-based institutional investor focused on high-growth, early-stage public companies, setting out the principal terms and conditions for a $100 million equity line of credit, expandable to $500 million. Pursuant to the Term Sheet, NewGen will have the option, but not the obligation, to sell to White Lion up to $100.0 million in shares of common stock over an initial 36-month period, with the potential to increase to $300.0 million upon substantial
BANGKOK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), today announced that on October 8, 2024, the Company received a letter (the "Deficiency Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is currently not in compliance with the closing bid price requirement under Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Rule"). The Deficiency Letter notified the Company that, for the preceding 30 consecutive business days, the Company's Class A Ordinary Shares (the "Class A Shares") did not meet the minimum closing bid price of $1 per share pursuant to
Total Revenues Reach US$5.1 MillionGross Profit Increases by 9.4% to US$1.7 MillionNet Income of US$0.1 million BANGKOK, Thailand, Aug. 21, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that on August 19, 2024, the Company filed its 2023 annual report (20-F) with the SEC. 2023 Financial Highlights Total revenues were US$5.1 million in the full year of 2023.Gross profit increased by 9.4% to US$1.7 million from US$1.5 million in the full year of 2022.Gross margin was 32.8%, compared to 25.9% in the full year of 202
6-K - NewGenIvf Group Ltd (0001981662) (Filer)
6-K - NewGenIvf Group Ltd (0001981662) (Filer)
424B3 - NewGenIvf Group Ltd (0001981662) (Filer)
SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)
SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)
3 - NewGenIvf Group Ltd (0001981662) (Issuer)
Shares of General Dynamics Corporation (NYSE:GD) fell sharply during Wednesday's session after the company reported worse-than-expected second-quarter EPS results. Revenue for the quarter increased 18% year-over-year to $11.976 billion, beating the consensus of $11.438 billion. EPS of $3.26 (up 20.7% YoY) missed the consensus of $3.29, according to data from Benzinga Pro. General Dynamics shares declined 5.2% to $279.26 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers NuZee, Inc. (NASDAQ:NUZE) jumped 192% to $3.01. Dermata Therapeutics, Inc. (NASDAQ:DRMA) rose 142.4% to $3.0799 after falling over 22% on Tuesday. Selina Hospitality PLC
Shares of Enphase Energy, Inc. (NASDAQ:ENPH) rose sharply in today's pre-market trading after the company reported second-quarter financial results. Enphase Energy reported second-quarter revenue of $303.46 million, missing the consensus estimate of $309.67 million, according to Benzinga Pro. The company reported adjusted earnings of 43 cents per share, missing analyst estimates of 48 cents per share. Enphase Energy shares gained 6.2% to $110.10 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Dermata Therapeutics, Inc. (NASDAQ:DRMA) rose 146.2% to $3.20 in pre-market trading after falling over 22% on Tuesday. NuZee, Inc. (NASDAQ:NUZ